<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04326270</url>
  </required_header>
  <id_info>
    <org_study_id>GR037133</org_study_id>
    <nct_id>NCT04326270</nct_id>
  </id_info>
  <brief_title>Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs</brief_title>
  <official_title>Crossover Comparison of Tidal Volume Delivery During Nasal Intermittent Positive Pressure Ventilation in Preterm Infants: Infant Cannula vs. Nasal Continuous Positive Airway Pressure Prongs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arkansas Children's Hospital Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arkansas Children's Hospital Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Crossover bedside clinical study to examine relative tidal volume delivery during nasal
      intermittent positive pressure ventilation (NIPPV) and directly compare the RAM® infant
      cannula to a nasal continuous positive airway pressure (nCPAP) delivery system in vivo. The
      study population will consist of preterm neonates with mild respiratory insufficiency who are
      receiving NIPPV, non-invasive neurally adjusted ventilatory assist (NIV NAVA), or nCPAP.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bedside crossover study of neonates with mild respiratory distress receiving NIPPV. Infants
      serve as their own controls and are randomized to initial interface of either RAM® infant
      cannula or Miniflow® nCPAP prongs. Infants are instrumented with the following monitoring
      equipment: Edi orogastric tube to measure electrical activity of the diaphragm,
      transcutaneous monitor to measure transcutaneous CO2 and O2, pulse oximeter to measure heart
      rate and oxygen saturation, and respiratory inductance plethysmography (RIP) bands around the
      chest and abdomen to measure breathing movements and relative Vt (arbitrary units, a.u.).
      Data are continuously and simultaneously acquired using a data acquisition system. After 10
      minutes of stabilization, infants receive 5 minutes of NIPPV on each of a sequence of four
      commonly used pressure settings (expressed as peak inspiratory pressure / positive end
      expiratory pressure): 16/5, 16/8, 20/5, 20/8. This sequence is not randomized and is constant
      between interfaces. Subjects are then placed on the alternate interface, and the sequence is
      repeated. Events (&quot;breaths&quot;) are separated into 3 types: patient effort synchronized with
      NIPPV breaths (type I), NIPPV breaths without patient effort (type II), and patient effort
      without NIPPV breaths (type III).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 7, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Relative tidal volume delivery, breath type I</measure>
    <time_frame>1 hour</time_frame>
    <description>Relative tidal volume measured in arbitrary units (AU) via RIP bands during synchronized breaths</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative tidal volume delivery, breath type II</measure>
    <time_frame>1 hour</time_frame>
    <description>Relative tidal volume measured in arbitrary units (AU) via RIP bands during ventilator-driven breaths</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relative tidal volume delivery, breath type III</measure>
    <time_frame>1 hour</time_frame>
    <description>Relative tidal volume measured in arbitrary units (AU) via RIP bands during patient-driven breaths</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ventilator pressure delivery</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator flow delivery</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcutaneous carbon dioxide tension</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcutaneous oxygen tension</measure>
    <time_frame>1 hour</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Respiratory Distress Syndrome in Premature Infant</condition>
  <arm_group>
    <arm_group_label>nCPAP prongs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Infant cannula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal interface</intervention_name>
    <description>Randomized to initial interface of nCPAP prongs or infant cannula</description>
    <arm_group_label>Infant cannula</arm_group_label>
    <arm_group_label>nCPAP prongs</arm_group_label>
    <other_name>Neotech RAM infant cannula</other_name>
    <other_name>Miniflow Nasal CPAP Prongs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronologic age less than 28 days

          -  Gestational age at birth between 24 weeks 0 days to 34 weeks 6 days

          -  Currently receiving NIPPV, NIV NAVA, or nCPAP

        Exclusion Criteria:

          -  Oxygen requirement greater than 40%

          -  Peak inspiratory pressure greater than 20 cm H2O

          -  Major congenital anomalies of the heart or lungs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>28 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ashley Lynch, M.D.</last_name>
    <phone>501-412-0988</phone>
    <email>allynch@uams.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Lynch, M.D.</last_name>
      <phone>501-412-0988</phone>
      <email>allynch@uams.edu</email>
    </contact>
    <investigator>
      <last_name>Ashley L Lynch, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2020</study_first_posted>
  <last_update_submitted>March 26, 2020</last_update_submitted>
  <last_update_submitted_qc>March 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Arkansas Children's Hospital Research Institute</investigator_affiliation>
    <investigator_full_name>Ashley L. Lynch</investigator_full_name>
    <investigator_title>Principle Investigator</investigator_title>
  </responsible_party>
  <keyword>nasal intermittent positive pressure ventilation</keyword>
  <keyword>non-invasive ventilation</keyword>
  <keyword>nasal continuous positive airway pressure prongs</keyword>
  <keyword>infant nasal cannula</keyword>
  <keyword>tidal volume</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

